Excellent Response to β-1 Adrenergic Receptor Blockade (metoprolol) and Exercise Restriction in High-risk Type 1 Long QT Syndrome. A 22-year Follow-up

Overview

Journal HeartRhythm Case Rep

Date 2022 May 2

PMID 35492848

Authors

Williams Tejeda-Mollinedo

Sergio Diaz-Tostado

Jorge Gomez-Flores

Santiago Nava-Townsend

Moises Levinstein-Jacinto

Manlio F Marquez

Affiliations

Soon will be listed here.

Citing Articles

The Alliance Against Sudden Death, a 17-year journey for an original initiative of the Inter-American Society of Cardiology.

Marquez-Murillo M, Bazbaz A, Hernandez F, Gonzalez-Hermosillo J Heart Rhythm O2. 2024; 5(8):515-519.

PMID: 39263617 PMC: 11385405. DOI: 10.1016/j.hroo.2024.05.006.

References

Ahn J, Kim H, Choi J, Lee K, Shim J, Ahn H . Effectiveness of beta-blockers depending on the genotype of congenital long-QT syndrome: A meta-analysis. PLoS One. 2017; 12(10):e0185680. PMC: 5653191. DOI: 10.1371/journal.pone.0185680. View

Moss A, Shimizu W, Wilde A, Towbin J, Zareba W, Robinson J . Clinical aspects of type-1 long-QT syndrome by location, coding type, and biophysical function of mutations involving the KCNQ1 gene. Circulation. 2007; 115(19):2481-9. PMC: 3332528. DOI: 10.1161/CIRCULATIONAHA.106.665406. View

Michael Vincent G, Schwartz P, Denjoy I, Swan H, Bithell C, Spazzolini C . High efficacy of beta-blockers in long-QT syndrome type 1: contribution of noncompliance and QT-prolonging drugs to the occurrence of beta-blocker treatment "failures". Circulation. 2009; 119(2):215-21. DOI: 10.1161/CIRCULATIONAHA.108.772533. View

Barsheshet A, Dotsenko O, Goldenberg I . Congenital long QT syndromes: prevalence, pathophysiology and management. Paediatr Drugs. 2014; 16(6):447-56. DOI: 10.1007/s40272-014-0090-4. View

Priori S, Napolitano C, Schwartz P, Grillo M, Bloise R, Ronchetti E . Association of long QT syndrome loci and cardiac events among patients treated with beta-blockers. JAMA. 2004; 292(11):1341-4. DOI: 10.1001/jama.292.11.1341. View

Chockalingam P, Crotti L, Girardengo G, Johnson J, Harris K, van der Heijden J . Not all beta-blockers are equal in the management of long QT syndrome types 1 and 2: higher recurrence of events under metoprolol. J Am Coll Cardiol. 2012; 60(20):2092-9. PMC: 3515779. DOI: 10.1016/j.jacc.2012.07.046. View

Du F, Wang G, Wang D, Su G, Yao G, Zhang W . Targeted next generation sequencing revealed a novel deletion-frameshift mutation of KCNH2 gene in a Chinese Han family with long QT syndrome: A case report and review of Chinese cases. Medicine (Baltimore). 2020; 99(16):e19749. PMC: 7220270. DOI: 10.1097/MD.0000000000019749. View

MOSS A, Zareba W, Hall W, Schwartz P, Crampton R, Benhorin J . Effectiveness and limitations of beta-blocker therapy in congenital long-QT syndrome. Circulation. 2000; 101(6):616-23. DOI: 10.1161/01.cir.101.6.616. View

Schwartz P, Priori S, Cerrone M, Spazzolini C, Odero A, Napolitano C . Left cardiac sympathetic denervation in the management of high-risk patients affected by the long-QT syndrome. Circulation. 2004; 109(15):1826-33. DOI: 10.1161/01.CIR.0000125523.14403.1E. View

10.

Shimizu W, Tanabe Y, Aiba T, Inagaki M, Kurita T, Suyama K . Differential effects of beta-blockade on dispersion of repolarization in the absence and presence of sympathetic stimulation between the LQT1 and LQT2 forms of congenital long QT syndrome. J Am Coll Cardiol. 2002; 39(12):1984-91. DOI: 10.1016/s0735-1097(02)01894-6. View

11.

Schwartz P, Priori S, Spazzolini C, MOSS A, Vincent G, Napolitano C . Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation. 2001; 103(1):89-95. DOI: 10.1161/01.cir.103.1.89. View

12.

Shimizu W, Antzelevitch C . Cellular basis for the ECG features of the LQT1 form of the long-QT syndrome: effects of beta-adrenergic agonists and antagonists and sodium channel blockers on transmural dispersion of repolarization and torsade de pointes. Circulation. 1998; 98(21):2314-22. DOI: 10.1161/01.cir.98.21.2314. View

13.

Priori S, Blomstrom-Lundqvist C, Mazzanti A, Blom N, Borggrefe M, Camm J . 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the.... Eur Heart J. 2015; 36(41):2793-2867. DOI: 10.1093/eurheartj/ehv316. View

14.

Goldenberg I, Moss A, Peterson D, McNitt S, Zareba W, Andrews M . Risk factors for aborted cardiac arrest and sudden cardiac death in children with the congenital long-QT syndrome. Circulation. 2008; 117(17):2184-91. PMC: 3944375. DOI: 10.1161/CIRCULATIONAHA.107.701243. View

15.

Priori S, Schwartz P, Napolitano C, Bloise R, Ronchetti E, Grillo M . Risk stratification in the long-QT syndrome. N Engl J Med. 2003; 348(19):1866-74. DOI: 10.1056/NEJMoa022147. View